Mario Negri Institute For Pharmacological Research

This study tested whether adding the drug ATRA to standard hormone therapy (anastrozole) could shrink tumors in postmenopausal women with a common type of early breast cancer (HR-positive/HER2-negative). The treatment was given for 4 weeks before surgery. The study was stopped ea…

This study tested whether adding an immunotherapy drug (durvalumab) to standard chemotherapy before radiation could help people with large, inoperable stage III lung cancer become eligible for radiation therapy. The goal was to shrink tumors enough to safely deliver radiation. Th…